-
Abstract Number: 344
Factors Associated with the Disappearance of Calcifications Following Ultrasound Guided Percutaneous Lavage of Rotator Cuff Calcific Tendinopathy: A Post Hoc Analysis of a Randomized Controlled Trial
-
Abstract Number: 345
Associations of Serum Uric Acid with Cardiovascular Disease Risk: Data from the Korea National Health and Nutrition Examination Survey
-
Abstract Number: 346
Subtypes of Gout Based on Comorbidity Patterns Among Black Patients in the US General Population – Cluster Analysis of the National Health and Nutrition Examination Survey 2007-2016
-
Abstract Number: 347
Patterns and Clinico-Radiological Correlates of Symptomatic Atlantoaxial Joint Involvement in Patients with Calcium Pyrophosphate Deposition Disease
-
Abstract Number: 348
Patterns of Newer Gout Medication Use in a U.S. Electronic Health Record-Based Registry
-
Abstract Number: 349
Carotid Atherosclerosis and Sonographic Signs of Urate Crystal Deposits in Patients with Gout: An Association Study
-
Abstract Number: 350
Rapid Reduction in Uric Acid Is Associated with Recurrent Cardiovascular Events
-
Abstract Number: 351
Risk Factors for Cutaneous Reactions to Allopurinol in Kinh Vietnameses: Results of a Prospective Study in Ho Chi Minh City
-
Abstract Number: 352
Primary Hyperparathyroidism Is Associated with a Higher Level of Serum Uric Acid: A Systematic Review and Meta-analysis
-
Abstract Number: 353
Allopurinol Use and Type 2 Diabetes Incidence Among Patients with Gout: A VA Cohort Study
-
Abstract Number: 354
Evaluation of Opioid Analgesia in Hospitalized Patients with Acute Crystal Induced Arthritis
-
Abstract Number: 355
Comparative Risk of Cardiovascular Events in US Veterans with Gout Treated with Febuxostat versus Allopurinol
-
Abstract Number: 356
Gout Flares Become Infrequent During a Treat-to-target Strategy over One Year: Data from the NOR-Gout Study
-
Abstract Number: 357
Longitudinal Variation in Repeat Serum Urate Levels: Relationship with Hyperuricemia Classification
-
Abstract Number: 358
Emergency Department Encounters in a Large US Payer Database: Tophaceous versus Non-tophaceous Gout Patients
- « Previous Page
- 1
- …
- 24
- 25
- 26
- 27
- 28
- …
- 198
- Next Page »